Recall Z-2764-2019— ELITech Group B.V.
Class III · Terminated
Class III FDA medical device recall by ELITech Group B.V., initiated 2016-07-12, terminated 2022-02-04. It names one FDA 510(k) clearance: K102647. Product: Viva-ProE Systems, Model # 6003-670, UDI: 03661540600357 - Product Usage: The ELITech Clinical Systems Selectra ProM is an automated clinical chemistry system intended for use in clinical laboratories. It is intended to be used for a variety of assay methods that have been applied to spectrophotometric and electrochemical techniques. The system has two core modules: one consisting of a spectrophoto-metric system for measurement of analytes using spectrophotometric techniques, such as end point, rate and turbidometric assays. The second module is an electro-meter used for measurement of electrolytes.. Reason: Software malfunction; The action being taken due to the device becoming inoperable due to software lockup..
- Recalling firm
- ELITech Group B.V.
- Classification
- Class III
- Status
- Terminated
- Initiated
- 2016-07-12
- Terminated
- 2022-02-04
- Firm location
- Spankeren, N/A, Netherlands
510(k) clearances named in this recall
1 on FDA's recordK-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.
Product description
Viva-ProE Systems, Model # 6003-670, UDI: 03661540600357 - Product Usage: The ELITech Clinical Systems Selectra ProM is an automated clinical chemistry system intended for use in clinical laboratories. It is intended to be used for a variety of assay methods that have been applied to spectrophotometric and electrochemical techniques. The system has two core modules: one consisting of a spectrophoto-metric system for measurement of analytes using spectrophotometric techniques, such as end point, rate and turbidometric assays. The second module is an electro-meter used for measurement of electrolytes.
Reason for recall
Software malfunction; The action being taken due to the device becoming inoperable due to software lockup.
Data sourced from openFDA. This site is unofficial and independent of the FDA.